1 not yet recruiting, 1 unknown. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Immune Tolerance: new trials by email Literature Review of Immune Tolerance trials Research Report on Immune Tolerance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease Placebo plus immunosuppression, Rivaroxaban plus immunosupression - Behcet Disease, Behcet Disease and Vascular Involvement | Phase 3 | Not yet recruiting | Marmara University | 110 | 2025-04-30 | 2025-04-13 |
| Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Immune Tolerance - ESRD | Phase 1 | Unknown | Everett Meyer | 25 | 2010-07-14 | 2023-06-18 |
Behcet Syndrome (1) · Kidney Failure, Chronic (1) · Postthrombotic Syndrome (1) · Venous Thrombosis (1)
Everett Meyer (1) · Marmara University (1)
Turkey (Türkiye) (1) · United States (1)
Fatma Alibaz-Oner, Prof (1) · Stephan Busque, MD,MS (1)
P01HL075462 (1)